QioMed
Curated by SignalBio-informatics drug discovery company using G-Coupled Protein Receptors as targets
Overview
QioMed is an American bio-informatics drug discovery company which works specifically on trans-membrane proteins called GCPRs (G-couples protein receptors). The company's in-silico technology is based on first principles modelling, i.e., mathematically representing quantum mechanical, reactive force field, and molecular dynamics principles in computational systems. They have drugs in CNS (Parkinson's) and Pancreatic cancer identified in drug validation stage. The diabetes drug in preclinical stage has been spun out to a company called GIR-x Metabolics in 2012
Key facts
- Founded
- 2010
- Headquarters
- Santa Fe, United States
- Stage
- Sign up to view
- Industry
- Health Technology